In a report released on March 7, Anthony Petrone from Mizuho Securities maintained a Buy rating on Cooper Co (COO – Research Report), with a price target of $120.00.
Anthony Petrone has given his Buy rating due to a combination of factors that suggest Cooper Co’s stock is an attractive investment opportunity. Despite a challenging start to the year, the company’s vision and IVF segments are expected to perform well amidst broader market uncertainties. The company’s full-year guidance for organic top-line growth remains strong, and early trends in the second quarter indicate potential improvements in these key areas.
Furthermore, the current valuation of Cooper Co’s shares, which are at a three-year low, presents an appealing entry point for investors. The stock is trading at a discount compared to its historical and peer multiples, making it a compelling option. Additionally, the contact lens and IVF markets have historically been resilient during significant US policy changes, suggesting that Cooper Co is well-positioned to benefit from potential shifts in the healthcare landscape.
In another report released on March 7, Citi also maintained a Buy rating on the stock with a $110.00 price target.